NIH #5T32CA071345-28
Training Program in Cancer Biology and Therapeutics
Active
- Amount
- $633K
- Period
- 1997-08-01 → 2028-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5T32CA071345-27
Training Program in Cancer Biology and Therapeutics
Active
- Amount
- $646K
- Period
- 1997-08-01 → 2028-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #2T32CA071345-26
Training Program in Cancer Biology and Therapeutics
Active
- Amount
- $523K
- Period
- 1997-08-01 → 2028-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5P50CA265826-04
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
Active
- Amount
- $2.3M
- Period
- 2022-08-01 → 2027-07-31
- PIs
- 2
- Est. capacity / PI
- ~4 students
Awarded at DANA-FARBER CANCER INST
NIH #5P50CA265826-03
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
Active
- Amount
- $2.3M
- Period
- 2022-08-01 → 2027-07-31
- PIs
- 2
- Est. capacity / PI
- ~4 students
Awarded at DANA-FARBER CANCER INST
NIH #5P50CA265826-02
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
Active
- Amount
- $2.2M
- Period
- 2022-08-01 → 2027-07-31
- PIs
- 2
- Est. capacity / PI
- ~3 students
Awarded at DANA-FARBER CANCER INST
NIH #1P50CA265826-01A1
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
Active
- Amount
- $2.4M
- Period
- 2022-08-01 → 2027-07-31
- PIs
- 2
- Est. capacity / PI
- ~4 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA137008-12
Non-genomic resistance mechanisms in EGFR-mutant lung cancer
Active
- Amount
- $392K
- Period
- 2009-03-01 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #2R01CA137008-11A1
Non-genomic resistance mechanisms in EGFR-mutant lung cancer
Active
- Amount
- $408K
- Period
- 2009-03-01 → 2027-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R61CA287026-03
A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications
Active
- Amount
- $234K
- Period
- 2024-02-12 → 2027-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R61CA287026-02
A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications
Active
- Amount
- $234K
- Period
- 2024-02-12 → 2027-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #1R61CA287026-01
A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications
Active
- Amount
- $234K
- Period
- 2024-02-12 → 2027-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5T32CA071345-24
Training Program in Cancer Biology and Therapeutics
- Amount
- $404K
- Period
- 1997-08-01 → 2023-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5T32CA071345-23
Training Program in Cancer Biology and Therapeutics
- Amount
- $386K
- Period
- 1997-08-01 → 2023-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5T32CA071345-25
Training Program in Cancer Biology and Therapeutics
- Amount
- $461K
- Period
- 1997-08-01 → 2023-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-10
Impact of heterogeneity on response to EGFR T790M inhibitors
- Amount
- $394K
- Period
- 2009-03-01 → 2021-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-09
Impact of heterogeneity on response to EGFR T790M inhibitors
- Amount
- $406K
- Period
- 2009-03-01 → 2020-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-08
Impact of heterogeneity on response to EGFR T790M inhibitors
- Amount
- $406K
- Period
- 2009-03-01 → 2020-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-07
Impact of heterogeneity on response to EGFR T790M inhibitors
- Amount
- $406K
- Period
- 2009-03-01 → 2020-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #2R01CA137008-06
Impact of heterogeneity on response to EGFR T790M inhibitors
- Amount
- $406K
- Period
- 2009-03-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R21CA156000-02
Repeat Biopsies in Lung Cancer to Define Targeted Resistance Mechanisms
- Amount
- $231K
- Period
- 2011-05-01 → 2013-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #1R21CA156000-01
Repeat Biopsies in Lung Cancer to Define Targeted Resistance Mechanisms
- Amount
- $191K
- Period
- 2011-05-01 → 2013-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL